Ceres Nanosciences, Inc. announces New Head of Sales Ceres is very excited to announce that Tara Jones-Roe has joined Ceres as the head of sales. She comes to Ceres with nearly 20 years of experience in the diagnostics and life sciences industry at Molecular Devices, Beckman Coulter, Thermo Fisher Scientific, and Roche Diagnostics. Tara brings [….]
Facility Logix Welcomes Two New Associate Project Managers to Bolster Project Teams Burtonsville, MD – August 1, 2019 – Facility Logix, a leading life science consulting firm, has hired two new Associate Project Managers: Jocaro L. Dodd and Wayne Mitchell. The new Associate Project Managers will be instrumental in addressing the facility-related needs of the firm’s [….]
CRB Announces the Promotion of Ben Skowronski to the Leader of the Maryland office CRB is excited to announce the promotion of Ben Skowronski to the leader of the Maryland office. Skowronski has demonstrated strong leadership and business development skills in the architecture, engineering and construction industries in the Northeast for 15 years and has [….]
MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform Dhana Chinnasamy, PhD, will oversee non-clinical and translational activities for MaxCyte’s autologous cell therapy platform for targeted cell-based immune therapies GAITHERSBURG, Md., July 23, 2019 /PRNewswire/ — MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that it [….]
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors GERMANTOWN, Md., July 18, 2019 /PRNewswire/ — Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, announced that Mary Ann Gray, Ph.D. has been appointed to the Company’s Board [….]
Immunomic Therapeutics Appoints Andrew Eisen, M.D., Ph.D. As VP, Clinical Development ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the appointment of Andrew Eisen, M.D., Ph.D. as VP, Clinical Development. Dr. Eisen is a translational medicine and clinical development specialist with over 20 years of experience in the biotech [….]
Viela Bio Appoints Mitchell Chan as Chief Financial Officer Mitchell Chan is appointed as Chief Financial Officer Gaithersburg, MD—July 1, 2019 – Viela Bio today announced the appointment of Mitchell Chan as Chief Financial Officer, effective July 1. In this role, he will be responsible for leading corporate financing, financial operations, treasury, investor relations, corporate communications [….]
BETHESDA, MD. June 24, 2019 – BrainScope announced today the appointment of Susan Hertzberg as Chief Executive Officer. This is the 4th equity-backed venture that Hertzberg will helm. She is a proven commercial stage leader with an impressive track record of bringing innovative products and services to market and profitably scaling and delivering exceptional market [….]
Immunomic Therapeutics Announces Promotion of Teri Heiland, Ph.D. to Chief Scientific Officer June 20, 2019 04:05 PM Eastern Daylight Time ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the promotion of Teri Heiland, Ph.D. to Chief Scientific Officer. In her new role, Dr. Heiland will oversee all of research [….]
Smithers Avanza Promotes Dr. Ira DuBey to President Smithers Avanza announced today that it has promoted Ira S. DuBey, Ph.D., to President of Smithers Avanza. Dr. DuBey will be responsible for the strategy of the bioanalytical services business as it expands in number of locations, team members, and capabilities. The promotion supports the organization’s commitment to the [….]
